Cardiac resynchronization for heart failure

By  |  November 15, 2010 | 

In this large trial of patients with class II-III CHF, EF<30%, and wide QRS, who received an ICD, they were randomized to+/- cardiac resynchronization therapy (CRT). Those in the resynchronization group had significantly fewer hospitalizations for CHF or all-cause death (primary outcome, occurred in 33% vs 40% of the groups). However, 13% of the CRT group experienced a device/implant-related adverse event, compared to only 7% of the non-CRT group. CRT can improve CHF hospitalization rates and all-cause death, at the expense of device-related adverse events (including pneumothorax, hemothorax, hematoma, infection, lead dislodgement, and coronary sinus dissection) (abstract)

Leave A Comment

About the Author:

Danielle Scheurer
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Categories

Related Posts

By  | June 18, 2018 |  0
Fill in the Blanks: Q: “The diagnosis of type 2 MI is associated with a _____ prognosis.  ___% of patients will live five years after their diagnosis.” The answer is a) POOR and b) a staggering 40%. I did not know that. However, what I am aware of is the ambiguity around Type 2 MIs and […]
By  | July 5, 2016 |  0
What comes to mind when you think of getting CME? I bet most of you would say sitting in an auditorium, whether that be during your local grand rounds or at our professional society meeting, like Hospital Medicine 16 in sunny San Diego this past March. Hanging out in the Twitterverse? Probably not so much… […]
By  | December 3, 2013 |  1
As a nurse practitioner in hospital medicine I have multiple opportunities to interact with all sorts of physician hospitalist colleagues, hospital medicine group leaders, quality officers etc.  Often their interactions with me take on a certain wary curiosity, like I am some exotic monkey or another creature that is unfamiliar to them.  If I am […]